|Application No.||Application Title||Issue Date|
|20120094830||ANTHRANILIC ACID DIAMIDE DERIVATIVE WITH HETERO-AROMATIC AND HETERO-CYCLIC SUBSTITUENTS|
The present invention relates to new insecticides of the formula (I)
in which R1, R2, R3, R4, R5, R6, A, Q and n can have the definitions stat...
The invention relates to novel chroman derivatives, stereoisomers and pharmaceutically acceptable salts of Formula I
wherein the substituents are as defined in the specification. They are useful in the treatm...
|20120029204||SYNTHESIS OF SUBSTITUTED-3-AMINOPYRAZOLES|
The present invention discloses a process of preparing compound of formula (I): wherein A, M, and Z are as defined herein. An example of a compound of formula (I) is 3-amino-1-methyl-1H-1′H-4,4′-bispyrazole.
This invention relates to pyrazole derivatives of formula (I)
or pharmaceutically acceptable salts, solvates or derivatives thereof, and to processes for the preparation thereof, intermediates used in their p...
|20110257014||1-(Heteroaryl)pyrazol-4-ylacetic acids, processes for their preparation and their use as herbicides and plant growth regulators|
The invention provides compounds of the formula (I) and salts thereof
which are described herein. The compounds (I) or salts thereof are suitable for use as herbicides and plant growth regulators, in particul...
|20110245157||DIMERIC 1-ARYLPYRAZOLE DERIVATIVES|
This invention provides for dimeric1-arylpyrazole compounds, of formulas (I), (II), and (III):
or salts thereof, and the use of these compounds against ectoparasites such as insects, arthropods and acarina. T...
|20110245262||COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS|
Disclosed are compounds and methods of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also, disclosed are pharmaceut...
|20110129455||INHIBITORS OF AKT ACTIVITY|
Invented are novel pyrrole compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis....
|20110098236||DIAMIDE INHIBITORS OF CYTOCHROME P450|
Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters to improve the...
|20100280036||Modulation of Pathogenicity|
The present invention relates to the use of compounds of the general Formula (I):
wherein in Formula (I),
|20100227846||SUBSTITUTED PYRAZOLE DERIVATIVE|
The present invention provides a novel pyrazole derivative and an androgen receptor antagonist containing the derivative. The present invention provides a compound represented by the formula (I′)
|20100160324||PYRAZOLE DERIVATIVES AS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASES|
The invention provides a compound of the formula (I): for use in medicine: or salts or tautomers or N-oxides or solvates thereof; wherein R1 is an optionally substituted heterocyclic group having from 3 to 12 ring members provided that the cyclic group joined...
|20100105729||ARYL-SUBSTITUTED HETEROCYCLIC PDE4 INHIBITORS AS ANTI-INFLAMMATORY AGENTS|
Disclosed herein are potent and selective aryl-substituted heterocyclic compounds, useful as inhibitors of phosphodiesterase 4 (PDE4), compositions comprising the same, and their application as pharmaceuticals for the treatment of disease. Methods of inhibition of PDE4 ...
|20100074842||Technetium-99m (I) Tricarbonyl Complexes with Tridentate Chelators for Myocardium Imaging|
Chelators of the formulae (I), (II) and (III) and tricarbonyl complexes of radioisotopes of Tc and Re bound to them, for use in myocardial imaging.
|20090143454||Pyrazoline Derivatives and Their Use As Pesticides|
The present invention relates to novel pyrazoline derivatives of the formula (I)
|20090099209||Compounds Useful in Therapy|
Compounds of formula (I),
or pharmaceutically acceptable derivatives thereof, wherein:
|20070232648||MODULATORS OF THE GLUCOCORTICOID RECEPTOR AND METHOD|
Novel non-steroidal compounds are provided which are glucocorticoid receptor modulators which are useful in treating diseases requiring glucocorticoid receptor agonist or antagonist therapy such as obesity, diabetes, inflammatory and immune disorders, and have the struc...